Literature DB >> 26791257

Erratum to: 'TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial'.

Dylan R Morris1, Margaret A Cunningham2, Anna A Ahimastos3, Bronwyn A Kingwell3, Elise Pappas1, Michael Bourke4, Christopher M Reid5, Theo Stijnen6, Ronald L Dalman7, Oliver O Aalami7, Jan H Lindeman6, Paul E Norman8, Philip J Walker9, Robert Fitridge10, Bernie Bourke4, Anthony E Dear11, Jenna Pinchbeck1, Rene Jaeggi1, Jonathan Golledge12,13.   

Abstract

Entities:  

Year:  2016        PMID: 26791257      PMCID: PMC4721016          DOI: 10.1186/s13063-016-1183-x

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


× No keyword cloud information.
Unfortunately, the original version of this article 1 [1] contained an error. Professor Jonathan Golledge is incorrectly referred to as deceased in the published article.
  1 in total

1.  TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.

Authors:  Dylan R Morris; Margaret A Cunningham; Anna A Ahimastos; Bronwyn A Kingwell; Elise Pappas; Michael Bourke; Christopher M Reid; Theo Stijnen; Ronald L Dalman; Oliver O Aalami; Jan H Lindeman; Paul E Norman; Philip J Walker; Robert Fitridge; Bernie Bourke; Anthony E Dear; Jenna Pinchbeck; Rene Jaeggi; Jonathan Golledge
Journal:  Trials       Date:  2015-06-17       Impact factor: 2.279

  1 in total
  1 in total

1.  Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury.

Authors:  Yi Fu; Yaqian Huang; Zhao Yang; Yufei Chen; Jingang Zheng; Chenfeng Mao; Zhiqing Li; Zhixin Liu; Bing Yu; Tuoyi Li; Meili Wang; Chanjuan Xu; Yiwei Zhou; Guizhen Zhao; Yiting Jia; Wei Guo; Xin Jia; Tao Zhang; Li Li; Ziyi Liu; Shengchao Guo; Mingliang Ma; Heng Zhang; Bo Liu; Junbao Du; Wengong Wang; Chaoshu Tang; Pei Gao; Qingbo Xu; Xian Wang; Jianfeng Liu; Jinpeng Sun; Wei Kong
Journal:  Cell Res       Date:  2021-01-28       Impact factor: 25.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.